Assessing the rationality of using statins in primary prevention of atherosclerotic coronary disease risk in patients with type 2 diabetes based on the ASCVD-10 scale at Hai Phong International General Hospital in 2020

Authors

  • Nguyễn Quang Chính Hai Phong Provincial Disease Control Center
  • Nguyễn Thị Thu Phương Hai Phong University of Medicine and Pharmacy; Hai Phong International Hospital

DOI:

https://doi.org/10.51403/0868-2836/2022/569

Keywords:

ASCVD-10, diabetes mellitus, statins

Abstract

Atherosclerotic cardiovascular disease (ASCVD) is the main clinical manifestation of cardiovascular disease, contributing greatly to the mortality rate of patients with diabetes. In 2019, the American Heart Association (ACC/AHA) released guidelines for cholesterol - lowering treatments to reduce cardiovascular risk from atherosclerosis. Therefore, we conducted a study on 2781 patients with type 2 diabetes to evaluate the rationality of using statins in the primary prevention of atherosclerotic coronary disease risk in this group of patients. type 2 diabetes based on the ASCVD - 10 scale at Hai Phong International General Hospital in 2020 according to the ACC/AHA recommendations in 2019. The results showed that 51% of patients 40 - 75 years old received only statins. Patients assigned to low-intensity statins accounted for the highest proportion with 57.0%, average statin intensity accounted for 39.5% and the lowest was high-intensity statin therapy with 3.5%. 59.8% of patients with type 2 diabetes in the 40 - 75 years old group at the hospital had rationally used statins as recommended by the ACC/AHA 2019. The results show the urgency and need to make efforts to ensure An increasing number of diabetic patients are receiving appropriate statin therapy for the primary prevention of atherosclerotic coronary disease risk.

Downloads

Download data is not yet available.

Published

18-02-2022

How to Cite

Chính, N. Q. ., & Phương, N. T. T. . (2022). Assessing the rationality of using statins in primary prevention of atherosclerotic coronary disease risk in patients with type 2 diabetes based on the ASCVD-10 scale at Hai Phong International General Hospital in 2020. Vietnam Journal of Preventive Medicine, 32(1), 334–341. https://doi.org/10.51403/0868-2836/2022/569

Most read articles by the same author(s)

1 2 3 4 > >>